BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heinrich MA, Martina B, Prakash J. Nanomedicine strategies to target coronavirus. Nano Today 2020;35:100961. [PMID: 32904707 DOI: 10.1016/j.nantod.2020.100961] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Domingues C, Santos A, Alvarez-Lorenzo C, Concheiro A, Jarak I, Veiga F, Barbosa I, Dourado M, Figueiras A. Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology. ACS Nano 2022. [PMID: 35729778 DOI: 10.1021/acsnano.2c00128] [Reference Citation Analysis]
2 Feng T, Nie C, Peng P, Lu H, Wang T, Li P, Huang W. Nanoagent-based theranostic strategies against human coronaviruses. Nano Res 2022;:1-15. [PMID: 35003529 DOI: 10.1007/s12274-021-3949-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Alphandéry E. Nano dimensions/adjuvants in COVID-19 vaccines. J Mater Chem B 2022. [PMID: 35166754 DOI: 10.1039/d1tb02408f] [Reference Citation Analysis]
4 Kashapov RR, Kashapova NE, Ziganshina AY, Syakaev VV, Khutoryanskiy VV, Zakharova LY. Interaction of mucin with viologen and acetate derivatives of calix[4]resorcinols. Colloids Surf B Biointerfaces 2021;208:112089. [PMID: 34500201 DOI: 10.1016/j.colsurfb.2021.112089] [Reference Citation Analysis]
5 Jermy BR, Ravinayagam V, Almohazey D, Alamoudi WA, Dafalla H, Akhtar S, Tanimu G. PEGylated green halloysite/spinel ferrite nanocomposites for pH sensitive delivery of dexamethasone: A potential pulmonary drug delivery treatment option for COVID-19. Appl Clay Sci 2021;:106333. [PMID: 34776567 DOI: 10.1016/j.clay.2021.106333] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Morgulchik N, Athanasopoulou F, Chu E, Lam Y, Kamaly N. Potential therapeutic approaches for targeted inhibition of inflammatory cytokines following COVID-19 infection-induced cytokine storm. Interface Focus 2022;12:20210006. [PMID: 34956607 DOI: 10.1098/rsfs.2021.0006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Rauf MA, Tasleem M, Bhise K, Tatiparti K, Sau S, Iyer AK. Nano-therapeutic strategies to target coronavirus. View (Beijing) 2021;2:20200155. [PMID: 34766165 DOI: 10.1002/VIW.20200155] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Huang S, Zhu Y, Zhang L, Zhang Z. Recent Advances in Delivery Systems for Genetic and Other Novel Vaccines. Adv Mater 2021;:e2107946. [PMID: 34914144 DOI: 10.1002/adma.202107946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kianpour M, Akbarian M, Uversky VN. Nanoparticles for Coronavirus Control. Nanomaterials (Basel) 2022;12:1602. [PMID: 35564311 DOI: 10.3390/nano12091602] [Reference Citation Analysis]
10 Ruseska I, Fresacher K, Petschacher C, Zimmer A. Use of Protamine in Nanopharmaceuticals-A Review. Nanomaterials (Basel) 2021;11:1508. [PMID: 34200384 DOI: 10.3390/nano11061508] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Rodríguez-Izquierdo I, Sepúlveda-Crespo D, Lasso JM, Resino S, Muñoz-Fernández MÁ. Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2022;14:e1774. [PMID: 35018739 DOI: 10.1002/wnan.1774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Liu H, Zhong W, Zhang X, Lin D, Wu J. Nanomedicine as a promising strategy for the theranostics of infectious diseases. J Mater Chem B 2021;9:7878-908. [PMID: 34611689 DOI: 10.1039/d1tb01316e] [Reference Citation Analysis]
13 Guo W, Lakshminarayanan H, Rodriguez-Palacios A, Salata RA, Xu K, Draz MS. Glycan Nanostructures of Human Coronaviruses. Int J Nanomedicine 2021;16:4813-30. [PMID: 34290504 DOI: 10.2147/IJN.S302516] [Reference Citation Analysis]
14 Yang X, You J, Wei Y, Li H, Gao L, Guo Q, Huang Y, Gong C, Yi C. Emerging nanomaterials applied for tackling the COVID-19 cytokine storm. J Mater Chem B 2021;9:8185-201. [PMID: 34528037 DOI: 10.1039/d1tb01446c] [Reference Citation Analysis]
15 Jafari A, Danesh Pouya F, Niknam Z, Abdollahpour-Alitappeh M, Rezaei-Tavirani M, Rasmi Y. Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms. Mol Biol Rep 2022. [PMID: 35235159 DOI: 10.1007/s11033-022-07132-7] [Reference Citation Analysis]
16 Rana MM. Polymer-based nano-therapies to combat COVID-19 related respiratory injury: progress, prospects, and challenges. J Biomater Sci Polym Ed 2021;32:1219-49. [PMID: 33787467 DOI: 10.1080/09205063.2021.1909412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Zare M, Thomas V, Ramakrishna S. Nanoscience and quantum science-led biocidal and antiviral strategies. J Mater Chem B 2021. [PMID: 34378553 DOI: 10.1039/d0tb02639e] [Reference Citation Analysis]
18 Brain D, Plant-Hately A, Heaton B, Arshad U, David C, Hedrich C, Owen A, Liptrott NJ. Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19. Adv Drug Deliv Rev 2021;178:113848. [PMID: 34182016 DOI: 10.1016/j.addr.2021.113848] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
19 Tammam SN, El Safy S, Ramadan S, Arjune S, Krakor E, Mathur S. Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2. J Control Release 2021;337:258-84. [PMID: 34293319 DOI: 10.1016/j.jconrel.2021.07.028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Cai Y, Tang C, Wei Z, Song C, Zou H, Zhang G, Ran J, Han W. Fused-Ring Small-Molecule-Based Bathochromic Nano-agents for Tumor NIR-II Fluorescence Imaging-Guided Photothermal/Photodynamic Therapy. ACS Appl Bio Mater 2021;4:1942-9. [DOI: 10.1021/acsabm.0c01576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Bonam SR, Kotla NG, Bohara RA, Rochev Y, Webster TJ, Bayry J. Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections. Nano Today 2021;36:101051. [PMID: 33519949 DOI: 10.1016/j.nantod.2020.101051] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
22 Wilson B, Mukundan Geetha K. Nanomedicine to deliver biological macromolecules for treating COVID-19. Vaccine 2022;40:3931-41. [PMID: 35660038 DOI: 10.1016/j.vaccine.2022.05.068] [Reference Citation Analysis]
23 Alqosaibi AI. Nanocarriers for anticancer drugs: challenges and perspectives. Saudi Journal of Biological Sciences 2022. [DOI: 10.1016/j.sjbs.2022.103298] [Reference Citation Analysis]
24 Sa-Nguanmoo N, Namdee K, Khongkow M, Ruktanonchai U, Zhao Y, Liang XJ. Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform. Nano Res 2021;:1-30. [PMID: 34659650 DOI: 10.1007/s12274-021-3832-y] [Reference Citation Analysis]